(1)
CLINICAL-LABORATORY, IMMUNOLOGICAL, PATHOGENETIC MANIFESTATIONS OF ANTIPHOSPHOLIPID SYNDROME AND IDENTIFICATION OF EFFECTIVE TREATMENT REGIMENS (REVIEWS). Spec. Jour. of Inno. Ref. and Dev. 2023, 15, 51-61.